ADVOCATE. CONNECT. INNOVATE.

About Us

CLSA Board of Directors

Officers


Members

Wade Ackerman

Wade Ackerman

Partner, Covington & Burling LLP

William Annett

Chief Executive Officer OncoCyte

David Beier, J.D.

Managing Director, Bay City Capital

Fritz Bittenbender

Senior Vice President, Government Affairs, Genentech

blatter

Victoria H. Blatter

Senior Vice President, U.S. Government Affairs, Amgen

Josh Brown

Josh Brown

National Vice President, State Government Relations, Pfizer

David H. Crean

Managing Director & Partner, Objective Capital Partners

kyle-gano

Kyle W. Gano, Ph.D.

Chief Business Development and Strategy Officer, Neurocrine Biosciences, Inc.

julie-gilmore

Julie Gilmore, Ph.D.

Site Head and Chief Operating Officer, Lilly Gateway Labs

Mark Ginestro

Principal, Healthcare and Life Sciences, KPMG

bryan giraudo

Bryan Giraudo

Chief Financial Officer, Gossamer Bio

grammer

Elizabeth Grammer, Esq.

Executive Vice President, General Counsel and Head of Human Resources, Ardelyx, Inc.

jennifer johnson

Jennifer A. Johnson, Ph.D.

Associate General Counsel, DuPont Nutrition & Biosciences

patrick-kaltenbach

Patrick Kaltenbach

Executive Vice President and President of the Life Sciences Segment, Becton, Dickinson and Company

andrew-kaplan

Andrew G. Kaplan

VP, U.S. Public Affairs, Takeda Pharmaceuticals USA, Inc.

Steve A. Kay, Ph.D., D.Sc.

Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California

Dirksen Lehman

Corporate Vice President, Public Affairs, Edwards Lifesciences

lynch

Casey Lynch

CEO, Co-founder, and Chairman, Cortexyme

John Maddalon

Principal, Life Science Practice, Deloitte

Sean McCarthy

President and Chief Executive Officer, CytomX

GraceHanMcMahon

Grace Han McMahon

Head of Transactions, Pacific Innovation Hub, Business Development & Licensing, Merck Research Laboratories

Shlomo Melmed, MB, ChB, MACP

Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System

Alan Mendelson

Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP

Jamey Millar

Senior Vice President, Managed Markets and Government Affairs, GlaxoSmithKline

Keith Murphy

Founder, CEO, and Chairman, Viscient Biosciences

William-J.-Newell

William J. Newell

Chief Executive Officer, Sutro Biopharma, Inc.

Nicols

John Nicols

President and Chief Executive Officer, Codexis

Chris Nolet

Christian W. Nolet

 

Joshua Ofman

Joshua J. Ofman, M.D., M.S.H.S

Chief of Corporate Strategy and External Affairs, Grail

christoph-pittius

Christoph Pittius, Ph.D.

Senior Vice President, Research Business Development, City of Hope

pugh

Stacey Pugh

Vice President and General Manager, Neurovascular, Medtronic

Ganesh Raman, Ph.D.

Associate Vice Chancellor for Research, California State University

chetana-rao

Chetana Rao, Ph.D.

Head, Site Strategy & Operations, Bristol-Myers Squibb, Redwood City

Stephen Richardson

Stephen Richardson

Co-Chief Executive Officer, Alexandria Real Estate (ARE)

Wendye Robbins, MD

President & CEO, Blade Therapeutics

Beth Roberts

Partner, Hogan Lovells US LLP

Daria Mochly Rosen

Daria Mochly-Rosen, Ph.D.

The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine

Terry Rosen, Ph.D.

Chief Executive Officer, Arcus Biosciences

Jennifer Ruddock joined Nektar Therapeutics in 2004 and currently serves as Senior Vice President, Strategy and Corporate Affairs. In this role, Ms. Ruddock oversees and leads investor relations, business development, corporate marketing, corporate and employee communications, and public and government affairs functions. Ms. Ruddock's professional experience spans over 25 years in biotechnology, technology and finance. Prior to joining Nektar, Ms. Ruddock held leadership roles in investor relations, financial communications and corporate marketing at a number of public companies, including Catellus Development Corporation (acquired by ProLogis) and Tumbleweed Communications (acquired by Axway). Prior to that, she worked at Montgomery Securities (acquired by Bank of America), a San Francisco-based investment bank which specialized in high technology and healthcare sectors. Ms. Ruddock began her career in medical device sales at Curtin Matheson Scientific, Inc. (acquired by Fisher Scientific). Ms. Ruddock received her undergraduate degree in neuroscience from Colgate University in 1991.

Jennifer Ruddock

Senior Vice President, Strategy & Corporate Affairs, Nektar Therapeutics

George Savage

George Savage M.D.

 

shultz

Fran Schulz

Partner, Assurance Services – Life Sciences Practice, Ernst & Young

Paolo Simas

Paulo Simas

Chief Creative Officer, W20 Group

LesleyStolz

Lesley Stolz, Ph.D.

Managing Director, Lasana Partners

elizabeth-thompson

Elizabeth Thompson, Ph.D.

Group Vice President, Development and External Search, Horizon Therapeutics

Robin Toft

Founder and President, Toft Group Executive Search, a ZRG Company

MohitTrikha

Mohit Trikha, Ph.D.

Vice President, Head of Oncology Early Development, AbbVie

VanWart

Harold E. Van Wart, Ph.D.

 

walsh

Bridget Walsh

Vice-President, Government Affairs and Public Policy, Boehringer Ingelheim

Jared Watkin

Senior Vice President, Diabetes Care, Abbott

Rick E Winningham

Chairman and CEO, Theravance Biopharma